DNAJB8 can also inhibit TP53 through ubiquitin degradation in human colon cancer by directly interacting and upregulating MDR1, leading to increased oxaliplatin resistance to colon cancer [92]. The gene discussed is TP53; the disease is malignant colon neoplasm.